Literature DB >> 1739123

Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans.

M E Rosenfeld1, S Ylä-Herttuala, B A Lipton, V A Ord, J L Witztum, D Steinberg.   

Abstract

In this study, the authors demonstrate the expression of mRNA and the presence of protein for macrophage colony-stimulating factor (MCSF) in atherosclerotic lesions from humans and rabbits. In situ hybridization of serial sections of human fatty streaks demonstrated expression of MCSF mRNA by cells dispersed throughout the lesions. Immunocytochemical staining with a panel of MCSF-specific antibodies showed extensive cell-associated staining of all of the cell types in the lesions. Immunocytochemical studies of atherosclerotic lesions from Watanabe heritable hyperlipidemic (WHHL) and cholesterol-fed rabbits demonstrated a similar cell-associated pattern of staining. There was no MCSF-specific staining of aortas from normal rabbits or of cultured aortic smooth muscle cells from either humans or rabbits. Macrophage-derived foam cells (MFC) were isolated from the aortas of ballooned, cholesterol-fed rabbits. A Northern blot demonstrated that RNA isolated from the MFC hybridized with a human cDNA probe for MCSF. RNA from alveolar macrophages isolated simultaneously from the same rabbits did not hybridize with the MCSF probe. Conditioned media from an 18- to 24-hour incubation of the MFC contained colony-stimulating activity as demonstrated in a mouse bone marrow culture assay. Most of this colony-stimulating activity was neutralized by preincubating the conditioned media with an MCSF-specific antibody.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739123      PMCID: PMC1886441     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response.

Authors:  A C van der Wal; P K Das; D Bentz van de Berg; C M van der Loos; A E Becker
Journal:  Lab Invest       Date:  1989-08       Impact factor: 5.662

2.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

Authors:  S Ylä-Herttuala; B A Lipton; M E Rosenfeld; T Särkioja; T Yoshimura; E J Leonard; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Uptake and degradation of low density lipoproteins in atherosclerotic rabbit aorta: role of local LDL modification.

Authors:  O Wiklund; L Mattsson; T Björnheden; G Camejo; G Bondjers
Journal:  J Lipid Res       Date:  1991-01       Impact factor: 5.922

4.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts.

Authors:  S Ylä-Herttuala; M E Rosenfeld; S Parthasarathy; E Sigal; T Särkioja; J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages.

Authors:  S Ishibashi; T Inaba; H Shimano; K Harada; I Inoue; H Mokuno; N Mori; T Gotoda; F Takaku; N Yamada
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

6.  Minimally modified low density lipoprotein is biologically active in vivo in mice.

Authors:  F Liao; J A Berliner; M Mehrabian; M Navab; L L Demer; A J Lusis; A M Fogelman
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

7.  Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1.

Authors:  J Stein; G V Borzillo; C W Rettenmier
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

8.  Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.

Authors:  M E Rosenfeld; J C Khoo; E Miller; S Parthasarathy; W Palinski; J L Witztum
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell.

Authors:  Y Watanabe; C O Jacob
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

10.  Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.

Authors:  H C Boyd; A M Gown; G Wolfbauer; A Chait
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

View more
  45 in total

1.  Control of vascular smooth-muscle cell growth by macrophage-colony-stimulating factor.

Authors:  T Herembert; J Gogusev; D L Zhu; T B Drueke; P Marche
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.

Authors:  J H Qiao; J Tripathi; N K Mishra; Y Cai; S Tripathi; X P Wang; S Imes; M C Fishbein; S K Clinton; P Libby; A J Lusis; T B Rajavashisth
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 3.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

4.  The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent.

Authors:  T A Hamilton; J A Major; G M Chisolm
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 5.  The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification.

Authors:  Linda Demer; Yin Tintut
Journal:  Circ Res       Date:  2011-06-10       Impact factor: 17.367

6.  To harness the revolution in vascular biology.

Authors:  J R Bender
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

7.  Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kip1) regulatory checkpoint.

Authors:  A S Antonov; D H Munn; F D Kolodgie; R Virmani; R G Gerrity
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 8.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

9.  Human monocyte colony-stimulating factor stimulates the gene expression of monocyte chemotactic protein-1 and increases the adhesion of monocytes to endothelial monolayers.

Authors:  Y J Shyy; L L Wickham; J P Hagan; H J Hsieh; Y L Hu; S H Telian; A J Valente; K L Sung; S Chien
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

10.  Normal human IgG prevents endothelial cell activation induced by TNFalpha and oxidized low-density lipoprotein atherogenic stimuli.

Authors:  N Ronda; F Bernini; R Giacosa; R Gatti; N Baldini; C Buzio; G Orlandini
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.